Robert A. Beardsley's most recent trade in Arbutus Biopharma Corp was a trade of 157,600 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on March 18, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Arbutus Biopharma Corp | Robert A. Beardsley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Mar 2025 | 157,600 | 157,600 | - | - | Stock Option (Right to Buy) | |
| Galera Therapeutics Inc | Robert A. Beardsley | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2023 | 135,000 | 135,000 | - | - | Stock Option (Right to Buy) | |
| Galera Therapeutics Inc | Robert A. Beardsley | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Nov 2022 | 10,000 | 75,651 | - | - | Stock Option | |
| Galera Therapeutics Inc | Robert A. Beardsley | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.07 per share. | 21 Nov 2022 | 10,000 | 108,191 (0%) | 0% | 1.1 | 10,700 | Common Stock |
| Galera Therapeutics Inc | Robert A. Beardsley | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Sep 2022 | 10,000 | 85,651 | - | - | Stock Option | |
| Galera Therapeutics Inc | Robert A. Beardsley | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.07 per share. | 12 Sep 2022 | 10,000 | 98,191 (0%) | 0% | 1.1 | 10,700 | Common Stock |
| Galera Therapeutics Inc | Robert A. Beardsley | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2022 | 75,000 | 75,000 | - | - | Stock Option (Right to Buy) | |
| Galera Therapeutics Inc | Robert A. Beardsley | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Dec 2021 | 20,000 | 95,651 | - | - | Stock Option | |
| Galera Therapeutics Inc | Robert A. Beardsley | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.07 per share. | 17 Dec 2021 | 20,000 | 88,191 (0%) | 0% | 1.1 | 21,400 | Common Stock |
| Galera Therapeutics Inc | Robert A. Beardsley | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2021 | 75,000 | 75,000 | - | - | Stock Option (Right to Buy) |